Abstract
1 The three dimensional requirements for inhibition of ACE (angiotensin converting enzyme) were investigated in order to facilitate design of a more potent and selective antihypertensive agent.
2 All compounds designed possessed a bicyclic unit incorporating carboxylate and amidic carbonyl groups together with a thiol-bearing side chain.
3 NMR spectroscopy of the bicyclic units and molecular mechanics calculations enabled the possible positions of the thiol group to be studied.
4 Determination of the positions of the thiol group conferring best inhibition in the active site of ACE permitted the probable location of the active site zinc ion to be identified. The intention was to replace the thiol side chain with a homophenylalanine unit to bind to the zinc ion and also to occupy the S1 site which fits the Phe8 side chain of angiotensin I.
5 Examination of a torsional angle ψ in a compound possessing poor inhibitory potency indicated correspondence to a high energy conformation of alanylproline. The bicyclic unit was modified to incorporate a seven- instead of a six-membered ring to bring ψ into the range of an accessible conformation of alanylproline. The corresponding IC50 resulting indicated that ψ was closer to that of the active conformations of enalaprilat and captopril.
6 Removal of one carbonyl improved the ACE inhibitory potency further.
7 The postulated active conformation of cilazaprilat is presented.
Keywords: angiotensin, angiotensin converting enzyme inhibitor, cilazapril, metalloproteinase
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Attwood M. R., Francis R. J., Hassall C. H., Kröhn A., Lawton G., Natoff I. L., Nixon J. S., Redshaw S., Thomas W. A. New potent inhibitors of angiotensin converting enzyme. FEBS Lett. 1984 Jan 9;165(2):201–206. doi: 10.1016/0014-5793(84)80169-6. [DOI] [PubMed] [Google Scholar]
- Monzingo A. F., Matthews B. W. Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases. Biochemistry. 1984 Nov 20;23(24):5724–5729. doi: 10.1021/bi00319a010. [DOI] [PubMed] [Google Scholar]
- Monzingo A. F., Matthews B. W. Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analogue mercaptans. Biochemistry. 1982 Jul 6;21(14):3390–3394. doi: 10.1021/bi00257a022. [DOI] [PubMed] [Google Scholar]
- Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977 Apr 22;196(4288):441–444. doi: 10.1126/science.191908. [DOI] [PubMed] [Google Scholar]
- Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Ikeler T. J., ten Broeke J., Payne L. G. A new class of angiotensin-converting enzyme inhibitors. Nature. 1980 Nov 20;288(5788):280–283. doi: 10.1038/288280a0. [DOI] [PubMed] [Google Scholar]
- SKEGGS L. T., Jr, MARSH W. H., KAHN J. R., SHUMWAY N. P. The existence of two forms of hypertensin. J Exp Med. 1954 Mar;99(3):275–282. doi: 10.1084/jem.99.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]